| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 4,588,687 | 4,588,687 |
| Net increase (decrease) in cash and cash equivalents | 437,904 | -678,783 |
| Cash and cash equivalents at beginning of period | 8,999,496 | - |
| Cash and cash equivalents at end of period | 9,437,400 | - |
CervoMed Inc. (CRVO)
CervoMed Inc. (CRVO)